Matuzumab Biosimilar - Research Grade
Product Sizes
1 mg
ICH4007-1MG
5 mg
ICH4007-5MG
10 mg
ICH4007-10MG
25 mg
ICH4007-25MG
50 mg
ICH4007-50MG
100 mg
ICH4007-100MG
200 mg
ICH4007-200MG
500 mg
ICH4007-500MG
1 g
ICH4007-1G
About this Product
- SKU:
- ICH4007
- Additional Names:
- Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, ERBB, ERBB1, HER1
- CE/IVD:
- RUO
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1-5 mg/ml
- Extra Details:
- Matuzumab biosimilar is a humanized IgG1 monoclonal antibody against human EGFR. As it only has approximately 10% murine origin it has limited immunogenicity, and being IgG1 it is capable of inducing antibody dependent cell cytotoxicity (ADCC).Matuzumab biosimilar is produced in mammalian (Chinese hamster ovary) cell culture.
- Formulation:
- Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
- Host:
- Human
- Immunogen:
- EGFR
- Isotype:
- IgG1
- Purity:
- >95%
- Purification:
- Protein A/G Purified
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Specificity:
- Detects human EGFR. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Matuzumab.
- Storage Conditions:
- 2-8[o]C Aliquot. Avoid freeze/thaw cycles., -70[o]C Aliquot. Avoid freeze/thaw cycles.
- Supplier:
- ichorbio
- Type:
- Antibody: Biosimilar Antibody
- Shipping Costs:
- Free shipping to UK Customers
- Manufacturer's Data Sheet:https://ichor.bio/productpdf/print/index/url_key/matuzumab-biosimilar-research-grade-ich4007/
